HCPLive Cardiology

Beginning in 2023, all new content from the editorial teams of Practical Cardiology, @EndocrineNetwrk, & @RheumatologyNet will be hosted on @MDMagazine. Learn how the merger helps us achieve our goal of improving the management of cardiovascular disease: ow.ly/sgC950MaOh9

Updated AHA/ACC guidelines for hypertrophic cardiomyopathy include a new emphasis on the roles of exercise and cardiac myosin inhibitors. Learn more: hcplive.com/view/new-cardi… #Cardiology #Cardiomyopathy

The @HCPLiveCardio April 2024 month in review spotlights #FDANews in cardiology and top updates from #ACC24. Learn more: hcplive.com/view/cardiolog…

At #ACC24, I sat down with the meeting's Young Investigator Award winner @SafChat to discuss her analysis of PARADIGM-HF and 2024 KDIGO Risk Classifications. Learn more: hcplive.com/view/safia-cha… @mvaduganathan @brendonneuen @scottdsolomon #HeartFailure #HFrEF @ACCmediacenter

🚨🚨 #PreAccChat with @APAC_Cardiology at 8 PM! 🚨🚨 Live Tweet using #PreACCchat or schedule them out using the questions list provided below! #Cardiology #Cardiotwitter

Part 2 of the Question List:

🚨 We are just days away from our #PreACCChat with @APAC_Cardiology on April 1 from 8-9 PM ET ! 🚨 Check out our 10 questions and posting times to prepare for the evening and participate on Monday night! #CardioTwitter #Cardiology #ACC24 Part 1:

Tune in Monday Night!

ACC.24 Tweet Chat on Monday from 8-9 PM from @HCPLiveNews and @APAC_Cardiology!! Questions list posted tomorrow on: hcplive.com/view/hcplive-a… #Cardiology #Cardiotwitter #ACC24

🚨 We are 1 week away from our pre-ACC Tweet Chat with Academy of Physician Associates In Cardiology 🚨 Check back later this week for the full list of questions or tune in on April 1 from 8 to 9 PM ET to participate! hcplive.com/view/hcplive-a… #CardioTwitter #ACC24 #ACC2024

🚨 We are 10 days away from our pre-ACC Tweet Chat with @APAC_Cardiology! 🚨 Join us on April 1 at 8 PM ET for a 10-question tweet chat discussing all things #ACC24, including the most anticipated sessions, pressing research needs, and more! hcplive.com/view/hcplive-a… #Cardiology

The FDA has approved the first oral antihypertensive agent with a new mechanism of action in more 30 years with the approval of aprocitentan (Tryvio; Idorsia Pharmaceuticals Ltd) for difficult-to-control hypertension. Learn more: hcplive.com/view/fda-appro… #FDANews #Hypertension

Last week, @HFSA published a scientific statement on cognitive impairment in #HeartFailure. I was lucky enough to sit in on a conversation between lead co-authors (@EiranGorodeski/@ParagGoyalMD) and HFSA president @JamesCFangMD. Clip below, link in next tweet for full video:

What are the top issues facing cardiology in 2024? DCRI's @SJGreene_md joins other leading experts to provide insights into key challenges and what can be done to overcome them: hcplive.com/view/experts-p…

How does SELECT change management of CV risk? In the latest #DiabetesDialogue special guest @LincoffMichael joins @DianaMIsaacs and @natalie_bellini to discuss SELECT, its implications, and the future of incretin therapies. hcplive.com/view/diabetes-… #Obesity #Diabetes #Cardiology

To commemorate the conclusion of #BlackHistoryMonth, HCPLive conducted a series of interviews with experts in diversity and equity in healthcare to address medicine's elephant in the room: how lacking clinical trial diversity impacts real-world care: hcplive.com/view/experts-p…

For American Heart Month, we asked 9 experts in cardiology for their perspective on the most prevalent issues facing the specialty today. hcplive.com/view/experts-p… #Cardiology #CardiovascularDisease @DLBHATTMD @DrLaxmiMehta @HCPLiveCardiology @HCPLiveNews

Earlier this week, we spoke with @DLBHATTMD, of @MountSinaiHeart, about a recent publication in @ESC_Journals highlighting the need for greater in-hospital initiation and uptitration of GDMT in #HeartFailure. hcplive.com/view/deepak-bh…

New research links maternal T1D to nearly all subtypes of congenital #heart defects, while overweight was associated only with certain defect types. hcplive.com/view/maternal-… #Cardiotwitter

Positive topline data from SEQUOIA-HCM announced by @Cytokinetics, with statistically significant benefit on exercise capacity and in all 10 prespecified secondary endpoints. Learn more: hcplive.com/view/cytokinet… #Cardiomyopathy #Cardiotwitter

Catch up on the latest in #cardiology by heading over to our cardiology resource center. hcplive.com/clinical/cardi…